These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23739459)

  • 1. [A pharmacoeconomical analysis of idiopathic epilepsy].
    Shagrova EV; Orekhova NV; Vlasov PN; Leonova MV; Shchderkina IO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(4 Pt 2):71-5. PubMed ID: 23739459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].
    Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
    Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
    Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of topamax in the treatment of epilepsy: clinical and pharmacoeconomic aspects].
    Gekht AB; Mil'chakova LE; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):40-4. PubMed ID: 18427458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States.
    Chen SY; Wu N; Boulanger L; Sacco P
    J Med Econ; 2013; 16(2):240-8. PubMed ID: 23171361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of sulbuthiamine (enerion) in the combined therapy of patients with symptomatic focal epilepsy].
    Litvinovich EF; Langeman TI; Litvinovich SF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(12):68-70. PubMed ID: 17274400
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of focal epilepsy in adults treated with polytherapy in France: the direct cost of drug resistance (ESPERA study).
    de Zélicourt M; de Toffol B; Vespignani H; Laurendeau C; Lévy-Bachelot L; Murat C; Fagnani F
    Seizure; 2014 May; 23(5):349-56. PubMed ID: 24560531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
    Zachry WM; Doan QD; Clewell JD; Smith BJ
    Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy].
    Szwed-Białozyt B; Marszał E
    Przegl Lek; 2003; 60 Suppl 1():5-9. PubMed ID: 12945154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct medical costs for partial refractory epilepsy in Mexico.
    García-Contreras F; Constantino-Casas P; Castro-Ríos A; Nevárez-Sida A; Estrada Correa Gdel C; Carlos Rivera F; Guzmán-Caniupan J; Torres-Arreola Ldel P; Contreras-Hernández I; Mould-Quevedo J; Garduño-Espinosa J
    Arch Med Res; 2006 Apr; 37(3):376-83. PubMed ID: 16513488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients.
    Fauser S; Huppertz HJ; Bast T; Strobl K; Pantazis G; Altenmueller DM; Feil B; Rona S; Kurth C; Rating D; Korinthenberg R; Steinhoff BJ; Volk B; Schulze-Bonhage A
    Brain; 2006 Jul; 129(Pt 7):1907-16. PubMed ID: 16714316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
    Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
    Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States.
    Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
    Epilepsia; 2010 May; 51(5):838-44. PubMed ID: 20002150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How long does it take for epilepsy to become intractable? A prospective investigation.
    Berg AT; Vickrey BG; Testa FM; Levy SR; Shinnar S; DiMario F; Smith S
    Ann Neurol; 2006 Jul; 60(1):73-9. PubMed ID: 16685695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure outcome after AED failure in pediatric focal epilepsy: impact of underlying etiology.
    Wirrell EC; Wong-Kisiel LC; Nickels KC
    Epilepsy Behav; 2014 May; 34():20-4. PubMed ID: 24681380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment registry in focal epilepsy (TRIP): multicenter observational study in Lebanon.
    Beydoun A; Sawaya MT; Alam E; Hmaimess G; Ezzeddine K; Younes F
    Seizure; 2015 Apr; 27():54-9. PubMed ID: 25891928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
    Vera-Llonch M; Brandenburg NA; Oster G
    Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
    Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.